Lasers, lights, and compounds for hair loss in aesthetics


      Hair loss is a common complaint that is often stressful for patients and a challenge for practitioners to treat. Fortunately, innovations in the field have contributed to growing evidence for several promising topical, oral, and light and energy-based therapies. We have reviewed the current literature about the efficacy of these treatments, including topical agents (finasteride, latanoprost, spironolactone, caffeine, and metformin), oral minoxidil, nutraceuticals, platelet-rich plasma, low-level laser therapy, fractional lasers, and laser-assisted drug delivery. In addition, several debates related to these treatments have been discussed, including post-finasteride syndrome, effects of biotin supplementation on laboratory testing, standardization of platelet-rich plasma and low-level laser therapy, and combination treatment to enhance hair transplantation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mazzarella F
        • Loconsole F
        • Cammisa A
        • Mastrolonardo M
        • Vena GA.
        Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course.
        J Dermatol Treat. 1997; 8: 189-192
        • Charuwichitratana S
        • Krisdapong P
        • Sumethiwit R
        • Tuchinda C.
        Randomized double-blind placebo controlled trial in the treatment of male andro-genetic alopecia with 0.1% finasteride solution.
        J Dermatol. 2003; 113: 881
        • Sitticharoenchai P.
        Clinical Evaluation of Topical Formulation of Finasteride in Male Androgenetic Alopecia.
        Chulalongkorn University, Bangkok, Thailand2006
        • Hajheydari Z
        • Akbari J
        • Saeedi M
        • Shokoohi L.
        Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia.
        Indian J Dermatol Venereol Leprol. 2009; 75: 47-51
        • Suchonawanit P
        • Srisuwanwattana P
        • Chalermroj N
        • Khunkhet S.
        A Randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
        J Eur Acad Dermatol Venereol. 2018; 32: 2257-2263
        • Suchonawanit P
        • Iamsumang W
        • Rojhirunsakool S.
        Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study.
        Am J Clin Dermatol. 2019; 20: 147-153
        • Caserini M
        • Radicioni M
        • Leuratti C
        • Annoni O
        • Palmieri R.
        A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers.
        Int J Clin Pharmacol Ther. 2014; 52: 842-849
        • Blume-Peytavi U
        • Issiakhem Z
        • Gautier S
        • et al.
        Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: a randomized, placebo-controlled, double-blind, noninferiority study.
        J Cosmet Dermatol. 2019; 18: 215-220
        • El-Ashmawy AA
        • El-Maadway IH
        • El-Magraby GM.
        Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
        J Dermatol Treat. 2018; 29: 55-64
        • Fischer TW
        • Hipler UC
        • Elsner P.
        Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.
        Int J Dermatol. 2007; 46: 27-35
        • Fischer TW
        • Herczeg-Lisztes E
        • Funk W
        • Zillikens D
        • Bíró T
        • Paus R.
        Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro.
        Br J Dermatol. 2014; 171: 1031-1043
        • Marotta JC
        • Patel G
        • Carvalho M
        • Blakeney S.
        Clinical efficacy of a topical compounded formulation in male androgenetic alopecia: minoxidil 10%, finasteride 0.1%, biotin 0.2%, and caffeine citrate 0.05% hydroalcoholic solution.
        Int J Pharm Compd. 2020; 24: 69-76
        • Otberg N
        • Teichmann A
        • Rasuljev U
        • Sinkgraven R
        • Sterry W
        • Lademann J.
        Follicular penetration of topically applied caffeine via a shampoo formulation.
        Skin Pharmacol Physiol. 2007; 20: 195-198
        • Bussoletti C
        • Tolaini MV
        • Celleno L.
        Efficacy of a cosmetic phyto-caffeine Shampoo in female androgenetic alopecia.
        G Ital Dermatol Venerol. 2020; 155: 492-499
        • Araoye EF
        • Thomas JAL
        • Aguh CU.
        Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin.
        JAAD Case Rep. 2020; 22: 106-108
        • Traish AM.
        Post-finasteride syndrome: a surmountable challenge for clinicians.
        Fertil Steril. 2020; 113: 21-50
        • Liu L
        • Zhao S
        • Li F
        • et al.
        Effect of 5α-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials.
        J Sex Med. 2016; 13: 1297-1310
        • Wessells H
        • Roy J
        • Bannow J
        • et al.
        PLESS Study Group. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.
        Urology. 2003; 61: 579-584
        • Gray SL
        • Semla TP.
        Post-finasteride syndrome.
        BMJ. 2019; 366: I5047
        • Unger JM
        • Till C
        • Thompson Jr, IM
        • et al.
        Long-term consequences of finasteride vs placebo in the Prostate Cancer Prevention Trial.
        J Natl Cancer Inst. 2016; 108: djw168
        • Fertig R
        • Shapiro J
        • Bergfeld W
        • Tosti A.
        Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome.
        Skin Appendage Disord. 2017; 2: 120-129
        • Seale LR
        • Eglini AN
        • McMichael AJ.
        Side effects related to 5 α-reductase inhibitor treatment of hair loss in women: a review.
        J Drugs Dermatol. 2016; 15: 414-419
        • Hu AC
        • Chapman LW
        • Mesinkovska NA.
        The efficacy and use of finasteride in women: a systematic review.
        Int J Dermatol. 2019; 58: 759-776
        • Fertig RM
        • Gamret AC
        • Darwin E
        • Gaudi S
        Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: a comprehensive review.
        Dermatol Online J. 2017; 23: 13030
        • Jimenez-Cauhe J
        • Saceda-Corralo D
        • Rodrigues-Barata R
        • et al.
        Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
        J Am Acad Dermatol. 2019; 81: 648-649
        • Lueangarun S
        • Panchaprateep R
        • Tempark T
        • Noppakun N.
        Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia.
        J Am Acad Dermatol. 2015; 72: AB113
        • Beach RA.
        Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the Five C's of oral therapy.
        Dermatol Ther. 2018; 31: e12707
        • Ramos PM
        • Sinclair RD
        • Kasprzak M
        • Miot HA.
        Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial.
        J Am Acad Dermatol. 2020; 82: 252-253
        • Gomolin A
        • Litvinov I
        • Netchiporouk E.
        Oral minoxidil: a possible new therapy for androgenetic alopecia.
        J Cutan Med Surg. 2020; 24: 88-89
        • Dickinson A
        • Shao A
        • Boyon N
        • Franco JC.
        Use of dietary supplements by cardiologists, dermatologists and orthopedists: report of a survey.
        Nutr J. 2011; 10: 20
        • John J
        • Cooley VC
        • Lipner S.
        Assessment of biotin supplementation among patients in an outpatient dermatology clinic.
        J Am Acad Dermatol. 2019; 81: 610-621
        • Li D
        • Radulescu A
        • Shrestha RT
        • et al.
        Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults.
        JAMA. 2017; 318: 1150-1160
        • Lipner S.
        Rethinking biotin therapy for hair, nail, and skin disorders.
        J Am Acad Dermatol. 2018; 78: 1236-1238
        • Farris PK
        • Rogers N
        • McMichael A
        • Kogan S.
        A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals.
        J Drugs Dermatol. 2017; 16: s141-s148
        • Thom E.
        Stress and the hair growth cycle: cortisol-induced hair growth disruption.
        J Drugs Dermatol. 2016; 15: 1001-1004
        • Auddy B
        • HJ Mitra A
        • Abedon B
        • Ghosal S.
        A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study.
        J Am Nutraceut Assoc. 2008; 11: 50-66
        • Institute of Medicine (US) and National Research Council (US) Committee on the Framework for Evaluating the Safety of Dietary Supplements
        Dietary Supplements: A Framework for Evaluating Safety.
        National Academies Press (US), Washington, DC2005 (. Appendix K, Prototype Focused Monograph: Review of Antiandrogenic Risks of Saw Palmetto Ingestion by Women. Available at:
        • Ablon G
        • Kogan S.
        A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair.
        J Drugs Dermatol. 2018; 17: 558-565
        • Ablon G.
        A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.
        Dermatol Res Pract. 2015; 2015841570
        • Ablon G.
        A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair.
        J Cosmet Dermatol. 2016; 15: 358-366
        • Hausauer AK
        • Humphrey S.
        The physician's guide to platelet-rich plasma in dermatologic surgery part I: definitions, mechanisms of action, and technical specifications.
        Dermatol Surg. 2020; 46: 348-357
        • Li ZJ
        • Choi HI
        • Choi DK
        • Sohn KC
        • et al.
        Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth.
        Dermatol Surg. 2012; 38: 1040-1046
        • Dohan Ehrenfest DM
        • Rasmusson L
        • Albrektsson T.
        Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
        Trends Biotechnol. 2009; 27: 158-167
        • Dohan Ehrenfest DM
        • Andia I
        • Zumstein MA
        • Zhang CQ
        • Pinto NR
        • Bielecki T.
        Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.
        Muscles Ligaments Tendons J. 2014; 4: 3-9
        • Magalon J
        • Chateau AL
        • Bertrand B
        • Louis ML
        • et al.
        DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices.
        BMJ Open Sport Exerc Med. 2016; 2e000060
        • Hesseler M
        • Shyam N.
        Platelet-rich plasma and its utilities in Alopecia: a systematic review.
        Dermatol Surg. 2019; 46: 93-102
        • Trink A
        • Sorbellini E
        • Bezzola P
        • Rodella L
        • et al.
        A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
        Br J Dermatol. 2013; 169: 690-694
        • Shumez H
        • Prasad P
        • Kaviarasan P
        • Deepika R.
        Intralesional platelet rich plasma vs intralesional triamcinolone in the treatment of alopecia areata: a comparative study.
        Int J Med Res Heal Sci. 2015; 4: 118
        • El Taieb MA
        • Ibrahim H
        • Nada EA
        • Seif Al-Din M
        Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation.
        Dermatol Ther. 2017; 30: e12437
        • Gentile P
        • Garcovich S
        • Bielli A
        • Scioli MG
        • Orlandi A
        • Cervelli V.
        The effect of platelet- rich plasma in hair regrowth: a randomized placebo-controlled trial.
        Stem Cell Transl Med. 2015; 4: 1317-1323
        • Tawfik AA
        • Osman MAR.
        The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study.
        J Cosmet Dermatol. 2018; 17: 47-53
        • Gentile P
        • Cole JP
        • Cole MA
        • Garcovich S
        • et al.
        Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems.
        Int J Mol Sci. 2017; 18: 408
        • Kachhawa D
        • Vats G
        • Sonare D
        • Rao P
        • Khuraiya S
        • Kataiya R.
        A spilt head study of efficacy of placebo versus platelet-rich plasma injections in the treatment of androgenic alopecia.
        J Cutan Aesthet Surg. 2017; 10: 86-89
        • Lee SH
        • Zheng Z
        • Kang JS
        • Kim DY
        • Oh SH
        • Cho SB.
        Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss.
        Wound Repair Regen. 2015; 23: 30-36
        • Puig CJ
        • Reese R
        • Peters M.
        Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia.
        Dermatol Surg. 2016; 42: 1243-1247
        • Ayatollahi A
        • Hosseini H
        • Shahdi M
        • AhmadNasrollahi S
        • et al.
        Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment?.
        Indian Dermatol Online J. 2017; 8: 460-464
        • Mapar MA
        • Shahriari S
        • Haghighizadeh MH.
        Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial.
        J Cosmet Laser Ther. 2016; 18: 452-455
        • Jha AK
        • Udayan UK
        • Roy PK
        • Amar AKJ
        • Chaudhary RKP.
        Original article: platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
        J Cosmet Dermatol. 2018; 17: 313-318
        • Alves R
        • Grimalt R.
        Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia.
        Dermatol Surg. 2018; 44: 126-130
        • Anitua E
        • Pino A
        • Martinez N
        • Orive G
        • Berridi D.
        The effect of plasma rich in growth factors on pattern hair loss.
        Dermatol Surg. 2017; 43: 658-670
        • Gupta AK
        • Foley KA.
        A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss.
        Dermatol Surg. 2017; 43: 188-197
        • Cohen PR.
        Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma–with or without concurrent bimatoprost and/or minoxidil.
        Dermatol Online J. 2019; 25: 13030
        • Kalia S
        • Lui H.
        Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis.
        Dermatol Clin. 2013; 31: 193-200
        • Wang X
        • Tian F
        • Soni SS
        • Gonzalez-Lima F
        • Liu H
        Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser.
        Sci Rep. 2016; 6: 30540
        • Karu TI
        • Kolyakov SF.
        Exact action spectra for cellular responses relevant to phototherapy.
        Photomed Laser Surg. 2005; 23: 355-361
        • Kim TH
        • Kim NJ
        • Youn JI.
        Evaluation of wavelength-dependent hair growth effects on low-level laser therapy: an experimental animal study.
        Lasers Med Sci. 2015; 30: 1703-1709
        • Liu KH
        • Liu D
        • Chen YT
        • SY Chin
        Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials.
        Lasers Med Sci. 2019; 34: 1063-1069
        • Faghihi F
        • Mozafarpoor S
        • Asilian A
        • et al.
        The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
        Indian J Dermatol Venereol Leprol. 2018; 84: 547-553
        • Perper M
        • Aldahan AS
        • Fayne RA
        • Emerson CP
        • Nouri K.
        Efficacy of fractional lasers in treating alopecia: a literature review.
        Lasers Med Sci. 2017; 32: 1919-1925
        • Lee GY
        • Lee SJ
        • Kim WS.
        The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss.
        J Eur Acad Dermatol Venereol. 2011; 25: 1450-1454
        • Kim WS
        • Lee HI
        • Lee JW
        • et al.
        Fractional photothermolysis laser treatment of male pattern hair loss.
        Dermatol Surg. 2011; 37: 41-51
        • Eckert MM
        • Gundin NL
        • Crespo RL.
        Alopecia areata: good response to treatment with fractional laser in 5 cases.
        J Cosmo Trichol. 2016; 2: 108
        • Yalici-Armagan B
        • Elcin G.
        The effect of neodymium: yttrium aluminum garnet and fractional carbon dioxide lasers on alopecia areata: a prospective controlled clinical trial.
        Dermatol Surg. 2016; 42: 500-506
        • Cho S
        • Choi MJ
        • Zheng Z
        • Goo B
        • Kim DY
        • Cho SB.
        Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients.
        J Cosmet Laser Ther. 2013; 15: 74-79
        • Lee WR
        • Shen SC
        • Aljuffali IA
        • Li YC
        • Fang JY.
        Erbium-yttrium- aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.
        J Pharm Sci. 2014; 103: 3542-3552
        • Salah M
        • Samy N
        • Fawzy MM
        • Farrag AR
        • Shehata H
        • Hany A.
        The effect of the fractional carbon dioxide laser on improving minoxidil delivery for the treatment of androgenetic alopecia.
        J Lasers Med Sci. 2020; 11: 29-36
        • Huang Y
        • Zhuo F
        • Linfeng L.
        Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors.
        Lasers Med Sci. 2017; 32: 1711-1718
        • Yu AJ
        • Luo YJ
        • Xu XG
        • et al.
        A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.
        Clin Exp Dermatol. 2018; 43: 775-781
        • MR Avram
        • Finney R
        • Rogers N.
        Hair transplantation controversies.
        Dermatol Surg. 2017; 43: S158-S162
        • Garg S.
        Outcome of intra-operative injected platelet-rich plasma therapy during follicular unit extraction hair transplant: a prospective randomised study in forty patients.
        J Cutan Aesthet Surg. 2016; 9: 157-164